By contrast, Latency II and III, seen in Hodgkin lymphoma and NPC, involve the reactivation of oncogenic viral genes like LMP1 and LMP2A via chromatin-opening mechanisms (Mesri et al., 2014; Zhou et al., 2025). This evidence concerns the gene PDLIM7 and Hodgkins lymphoma.